{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:55:26Z","timestamp":1762808126852},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.remn.2011.05.010","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T17:00:41Z","timestamp":1329843641000},"page":"261-266","source":"Crossref","is-referenced-by-count":1,"title":["Evaluaci\u00f3n de la eficacia y del impacto cl\u00ednico de la PET-18F-FDG en el diagn\u00f3stico de recurrencia del carcinoma medular de tiroides con calcitonina elevada y pruebas de imagen negativas"],"prefix":"10.1016","volume":"31","author":[{"given":"P.","family":"G\u00f3mez-Camarero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ortiz-de Tena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Borrego-Dorado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"V\u00e1zquez-Albertino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V.","family":"Ruiz-Franco-Baux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.","family":"Cuenca-Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2011.05.010_bib0005","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1210\/jc.2007-1211","article-title":"Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels","volume":"92","author":"Giraudet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","article-title":"Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"48","author":"Ong","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.05.010_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/107327480501200408","article-title":"Review of fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas","volume":"12","author":"Khan","year":"2005","journal-title":"Control cancer"},{"key":"10.1016\/j.remn.2011.05.010_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2265.2008.03229.x","article-title":"Long-term prognosis of medullary thyroid carcinoma","volume":"69","author":"Rendl","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.remn.2011.05.010_bib0025","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1210\/jc.2007-2496","article-title":"Calcitonin measurement in the evaluation of thyroid nodules in the United States: a costeffectiveness and decision analysis","volume":"93","author":"Cheung","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/jc.2003-030550","article-title":"Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders","volume":"89","author":"Elisei","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jc.2006-1590","article-title":"Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules","volume":"92","author":"Costante","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0040","first-page":"66","article-title":"18F-FDG PET Detection of lymph node metastases in medullary thyroid carcinoma","volume":"43","author":"Szak\u00e1ll","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2011.05.010_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ejso.2007.08.005","article-title":"The role of 18F-FDG PET\/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study","volume":"34","author":"Rubello","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.remn.2011.05.010_bib0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/jcem.82.5.3949","article-title":"Routine measurement of plasma calcitonin in nodular thyroid diseases","volume":"82","author":"Vierhapper","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s002590050533","article-title":"The value of 18fluorine fluorodeoxyglucose PET in patients with medullary thyroid cancer","volume":"27","author":"Brandt-Mainz","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2011.05.010_bib0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF03348014","article-title":"Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma","volume":"20","author":"Gasparoni","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.remn.2011.05.010_bib0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0039-6060(97)90208-7","article-title":"Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study","volume":"122","author":"Musholt","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.remn.2011.05.010_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002590050197","article-title":"Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours","volume":"25","author":"Adams","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2011.05.010_bib0075","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s002590100614","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicenter study","volume":"28","author":"Diehl","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2011.05.010_bib0080","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1245\/ASO.2004.10.015","article-title":"Plukker JThM. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer","volume":"11","author":"De Groot","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.remn.2011.05.010_bib0085","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1210\/jc.2007-0938","article-title":"Sensitivity and prognostic value of positron emission tomography with F-18-Fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy","volume":"92","author":"Oudoux","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remn.2011.05.010_bib0090","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.beem.2008.09.008","article-title":"Routine serum calcitonin measurement in the evaluation of thyroid nodules","volume":"22","author":"Elisei","year":"2008","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.remn.2011.05.010_bib0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejso.2010.01.001","article-title":"Dual PET\/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging","volume":"36","author":"Marzola","year":"2010","journal-title":"Eur J Surg Oncol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211001807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211001807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T22:28:22Z","timestamp":1561328902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698211001807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0212698211001807"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2011.05.010","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}